chronic plaque psoriasis. Psoriasis vulgaris
Conditions
Interventions
Intervention 1: Intervention group: The ointment contains D0orema ammoniacum and OSERIN which is used on the lesion twice a day for two months. The ointments are formulated and provided by a pharmaci
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: Chronic plaque form psoriasis patients Plaque size : lower than 10 % Age : older than 12 years old
Exclusion criteria
Exclusion criteria: Taking topical medicine in the last 14 days and systemic drug in the 30 last days Pregnancy or planning to be pregnant or breast feeding History of allergy to herbal medicines Presence of abnormal laboratory finding Taking local or systemic medicine that has a positive or negative effect on the course of the disease Having serious liver or kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plaque-type psoriasis patients with lesion involvement less than 10%. Timepoint: before the start of the intervention, day 14, day 28, day 42 and day 56 after the start of the intervention. Method of measurement: PASI questionnaire and DLQI questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating the quality of life based on the DLQI questionnaire. Timepoint: Before the intervention, week 2, week 4, week 6, week 8 after the intervention. Method of measurement: Dermatology Questionnaire for Quality of Life (DLQI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Naseriporyazdi
Mashhad University of Medical Sciences
Outcome results
None listed